Intelligent Bio Solutions Inc. (INBS)
INBS Stock Price Chart
Explore Intelligent Bio Solutions Inc. interactive price chart. Choose custom timeframes to analyze INBS price movements and trends.
INBS Company Profile
Discover essential business fundamentals and corporate details for Intelligent Bio Solutions Inc. (INBS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
23 Dec 2020
Employees
50.00
Website
https://gbs.incCEO
Harry Simeonidis
Description
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond this, the company is actively developing a SARS-CoV-2 Biosensor, intended to serve as a supplementary diagnostic tool to existing RNA virus detection methods. It also maintains a broad biosensor platform that encompasses diverse diagnostic modalities, including biochemistry, immunology, tumor marker identification, hormone analysis, and nucleic acid diagnostics. Incorporated in 2016 and based in New York, New York, the company was formerly known as GBS Inc. before adopting its current name in October 2022. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
INBS Financial Timeline
Browse a chronological timeline of Intelligent Bio Solutions Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 Aug 2026
EPS estimate is -$1.58, while revenue estimate is $1.22m.
Earnings released on 13 May 2026
EPS came in at -$1.80 falling short of the estimated $1.40 by -228.57%, while revenue for the quarter reached $1.06m , missing expectations by -85.27%.
Earnings released on 12 Feb 2026
EPS came in at -$2.82 falling short of the estimated $0.40 by -805.00%, while revenue for the quarter reached $896.77k , missing expectations by -83.70%.
Stock split effective on 16 Dec 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Nov 2025
EPS came in at -$3.50 falling short of the estimated -$1.50 by -133.33%, while revenue for the quarter reached $1.11m , missing expectations by -76.84%.
Earnings released on 15 Aug 2025
EPS came in at -$0.37 surpassing the estimated -$1.20 by +69.17%, while revenue for the quarter reached $843.88k , missing expectations by -80.37%.
Earnings released on 13 May 2025
EPS came in at -$0.44 surpassing the estimated -$2.80 by +84.29%, while revenue for the quarter reached $728.87k , missing expectations by -77.91%.
Earnings released on 13 Feb 2025
EPS came in at -$0.50 surpassing the estimated -$3.20 by +84.38%, while revenue for the quarter reached $607.49k , missing expectations by -73.59%.
Earnings released on 7 Nov 2024
EPS came in at -$0.70 falling short of the estimated -$0.53 by -32.08%, while revenue for the quarter reached $872.29k , missing expectations by -51.54%.
Earnings released on 19 Sept 2024
EPS came in at -$1.34 falling short of the estimated -$0.51 by -162.75%, while revenue for the quarter reached $727.82k , missing expectations by -48.01%.
Earnings released on 8 May 2024
EPS came in at -$1.43 falling short of the estimated -$0.87 by -64.37%, while revenue for the quarter reached $823.80k , missing expectations by -31.35%.
Earnings released on 9 Feb 2024
EPS came in at -$2.07 surpassing the estimated -$3.24 by +36.11%, while revenue for the quarter reached $764.06k , missing expectations by -23.59%.
Stock split effective on 29 Jan 2024
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Nov 2023
EPS came in at -$12.48 falling short of the estimated -$7.68 by -62.50%, while revenue for the quarter reached $796.09k , missing expectations by -20.39%.
Earnings released on 24 Aug 2023
EPS came in at -$22.93 falling short of the estimated -$19.93 by -15.05%, while revenue for the quarter reached $443.14k , missing expectations by -25.59%.
Earnings released on 11 May 2023
EPS came in at -$24.37 falling short of the estimated -$2.07 by -1.08k%, while revenue for the quarter reached $457.06k , beating expectations by +8.82%.
Earnings released on 14 Feb 2023
EPS came in at -$55.57 , while revenue for the quarter reached $356.68k .
Stock split effective on 10 Feb 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Nov 2022
EPS came in at -$16.23 surpassing the estimated -$24.00 by +32.38%, while revenue for the quarter reached $311.32k .
Earnings released on 31 Aug 2022
EPS came in at -$2.80 surpassing the estimated -$3.60 by +22.22%.
Earnings released on 10 May 2022
EPS came in at -$1.80 surpassing the estimated -$3.20 by +43.75%, while revenue for the quarter reached $192.50k .
Earnings released on 10 Feb 2022
EPS came in at -$4.60 falling short of the estimated -$3.20 by -43.75%, while revenue for the quarter reached $177.79k , missing expectations by -40.74%.
Earnings released on 12 Nov 2021
EPS came in at -$20.46 .
Earnings released on 16 Sept 2021
EPS came in at -$16.20 , while revenue for the quarter reached $1.61m .
INBS Stock Performance
Access detailed INBS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
